1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
- Contribution to journal › Scientific review
- 2010
-
Mark
CHEMOTHERAPY Current drugs still have potential in advanced ovarian cancer
- Contribution to journal › Debate/Note/Editorial